Get the full Brivfy experience on your smartphone app.

美国下令在减肥药上增加罕见眼病警示

· 50字阅读

美国下令在减肥药上增加罕见眼病警示

50字速览

美国食品药品监督管理局已下令GLP-1类药物的生产商,包括Ozempic、Wegovy、Mounjaro和Zepbound的生产商,增加有关NAION的警示。NAION是一种罕见的眼病,可导致突发性视力丧失,且可能是永久性的。诺和诺德表示,现有数据并不能证明二者存在因果关系。

Advertisement

为何重要

The warning covers widely used diabetes and weight-loss drugs. The American Academy of Ophthalmology advises patients not to stop their medication without talking to a doctor, and to see an eye specialist promptly if sudden vision loss occurs.

就这篇新闻问问 Brivfy AI

来源

Advertisement

Comments